Intellia Therapeutics

Youtube Subscribe

Open: 37.87 Close: 37.87 Change: 0.0

Our AI found unexpected things about Intellia Therapeutics.

Are looking for the most relevant information about Intellia Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Intellia Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Intellia Therapeutics are: Intellia, Therapeutics, price, Average, target, stock, Inc, and the most common words in the summary are: therapeutic, intellia, table, distribution, figure, company, stock, . One of the sentences in the summary was: (NTLA) Average Target Price: $82.70 Potential Upside: 117.8%. Other searches related …

Concept Map

Semantic Network

Stock Summary

Intellia Therapeutics Inc. (NTLA) Director Muna Bhanji sold 1,867 shares of the company in a transaction on Thursday, July 6th. Director Munani Bhanj now holds 12.

Today's Summary

Intellia Therapeutics Inc. (NTLA) Average Target Price: $82.70 Potential Upside: 117.8%. Average target price: $83.70 - potential upside: $81.70. Intellia Therapeutics stock price predictions for September 2025. Intellya Therapeutic stock price for month 74.11.11. Intellia Therapeutics aims at advancing CRISPR/Cas9-Cas9/Cas-9-based therapeutic candidates targeting a wide variety of diseases including trretyloid amsthystyloidosis amstylinosis. NTLA-5001 (IntelliaTherapeutics) 14.4.5.6.

Today's News

Intellia Therapeutics Inc. (NTLA) Average Target Price: $82.70 Potential Upside: 117.8%. Average target price: $83.70 - potential upside: $81.70. Intellia Therapeutics stock price predictions for September 2025. Intellya Therapeutic stock price for month 74.11.11. Intellia Therapeutics aims at advancing CRISPR/Cas9-Cas9/Cas-9-based therapeutic candidates targeting a wide variety of diseases including trretyloid amsthystyloidosis amstylinosis. NTLA-5001 (IntelliaTherapeutics) 14.4.5.6.

Stock Profile

" Intellia Therapeutics Inc. (NTLA) Director Muna Bhanji sold 1,867 shares of the company in a transaction on Thursday, July 6th. Cyndeo Wealth Partners LLC acquired a new position in Intellya Therapeutic, Inc. in Stock. Intellia Therapeutics is anticipated to post earnings of ($4.05) per share for the year. This forecast comes amidst a consensus estimate of $5.33 per share. Director Muna Bhanji now holds 12,526 shares in the company valued at $492,271. Wall Street analysts think its a good time to buy Intellia Therapeutics stock. Out of 16 sell side analysts who give forecasts on NTLA, the consensus analyst rating is a Strong Buy. NTLA does not generate passive income. Cambridge, MA, is hiring associate director, clinical data management in cambridge, massachusetts, united states. Sandia Investment Management LP acquired a new position in shares of Intellia Therapeutics in the fourth quarter valued at approximately $35,000. CWM LLC boosted its holdings in shares by 2,072.7% in the first quarter. Raymond James & Associates owns 0.06% of Intellia Therapeutics worth $1,972,000 at the end of the most recent quarter. Director Muna Bhanji sold 1,867 shares of the businesss stock in a transaction on Thursday, July 6th."

Keywords

This document will help you to evaluate Intellia Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Intellia Therapeutics are: Intellia, Therapeutics, price, Average, target, stock, Inc, and the most common words in the summary are: therapeutic, intellia, table, distribution, figure, company, stock, . One of the sentences in the summary was: (NTLA) Average Target Price: $82.70 Potential Upside: 117.8%. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #intellia #table #distribution #figure #company #stock.

Read more →

Youtube Subscribe

---